Australia
Intelligence de marché des dispositifs médicaux pour Australia. Changements réglementaires, concurrents et tendances d'achats.
Signaux récents
Wellumio raised $9.75M to commercialize its Axana portable brain imaging device for acute stroke detection.
MicroPort CardioFlow has launched its LBBOT Solution in Europe and Australia after regulatory approvals.
Vito Health Pty Ltd has registered a medical device with the FDA under product code KDT.
RIANCORP PTY LTD has registered a medical device with the FDA under product code NZY.
Philips partners with Disney to enhance pediatric MRI experiences globally, reducing anxiety and improving workflow.
A completed study in Australia assessed adherence to SAIZEN® using the Easypod™ device for pediatric growth hormone therapy.
Jardine Matheson will acquire I-MED Radiology Network for $2.4 billion, enhancing diagnostic imaging capabilities.
Signature Orthopaedics Pty Limited is registered with the FDA under code JWH, listing 2 products.
Aim Lab Automation Technologies Pty Ltd has registered a product with the FDA under code LXG.
Omniscient Neurotechnology Pty Ltd has registered a medical device with product code LLZ (3017102960).
OncoSil Medical received TGA approval for its device to treat LAPC with gemcitabine-based chemotherapy.
Multigate Co., Ltd registered a Class IIa Sterile Laryngeal Mask Airway with UDI-DI 09341601001708.
Alcidion acquires Telstra Health's Kyra patient flow solutions to enhance its enterprise patient flow business in Australia.
A study tests AI and wearables, like Apple Watch, for early infection detection in children undergoing chemotherapy.
The MEDRAD® Centargo CT Injector System by IMAXEON PTY LTD is classified as Class IIB medical device.
The study assessed Compumedics' Somfit device for equivalence to existing sleep monitoring technologies.
A study completed by Griffith University examines how flexible catheter materials affect PIVC performance and irritation.
A feasibility study for the DAISe EZ Thrombectomy Device will enroll 20 subjects across 5 centers in Australia.
The CANSCAN trial assessed the feasibility of dialysis staff using Vexev's ultrasound for arteriovenous fistula mapping.
IBD Medical Trading Pty Ltd. has registered a medical device with the FDA under product code MMK.